Results
8405
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,405 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
RHM | €1,119.00 | -2.2% | 169.3% | €48.6b | €1,203.57 | PE70.9x | E30.5% | 0.5% | Capital Goods | ||
ACE | SEK 2.95 | -13.0% | -67.4% | SEK 283.5m | SEK 7.68 | PB3.6x | E66.9% | n/a | Pharmaceuticals & Biotech | ||
TVTX | US$17.87 | -9.7% | 123.7% | US$1.6b | US$33.80 | PS6.8x | E65.0% | n/a | Pharmaceuticals & Biotech | ||
ZK | US$27.72 | 10.5% | n/a | US$7.8b | US$35.98 | PS0.7x | E71.6% | n/a | Automobiles | ||
ELABS | NOK 9.89 | -1.7% | -32.4% | NOK 1.0b | NOK 19.00 | PE116.2x | E88.2% | n/a | Software | ||
VOW | NOK 1.35 | -8.0% | -80.7% | NOK 392.6m | NOK 10.65 | PS0.4x | E120.9% | 0% | Commercial Services | ||
AFISH | NOK 59.00 | -5.6% | 4.4% | NOK 1.9b | NOK 81.00 | PE61.6x | E54.9% | n/a | Food, Beverage & Tobacco | ||
AXSM | US$118.78 | -6.6% | 67.5% | US$6.0b | US$173.00 | PS15x | E59.3% | n/a | Pharmaceuticals & Biotech | ||
INR | US$16.22 | -6.8% | n/a | US$952.7m | US$27.75 | PE2.1x | E23.2% | n/a | Energy | ||
KINS | US$13.72 | -17.4% | 268.8% | US$184.2m | US$18.00 | PE10.7x | E24.2% | 0% | Insurance | ||
ALNY | US$233.07 | -4.3% | 56.3% | US$31.7b | US$304.61 | PS13.4x | E58.6% | n/a | Pharmaceuticals & Biotech | ||
NOHAL | NOK 19.50 | -2.0% | -12.2% | NOK 1.0b | NOK 27.00 | PS11.5x | E56.3% | n/a | Food, Beverage & Tobacco | ||
CADLR | NOK 50.40 | -5.3% | 13.0% | NOK 17.7b | NOK 81.13 | PE166.2x | E70.7% | n/a | Capital Goods | ||
GAU | CA$1.66 | 0.6% | 4.4% | CA$457.6m | CA$3.10 | PS1.8x | E65.6% | n/a | Materials | ||
RCEL | US$8.32 | -4.7% | -49.4% | US$218.8m | US$16.29 | PS3.4x | E55.3% | n/a | Pharmaceuticals & Biotech | ||
PHM | €91.10 | -8.9% | 197.5% | €1.6b | €87.17 | PE60.7x | E40.8% | 0.7% | Pharmaceuticals & Biotech | ||
ARES | US$141.24 | -16.8% | 6.5% | US$48.9b | US$197.71 | PE71.5x | E42.5% | 3.2% | Diversified Financials | ||
ICOP | €9.24 | 5.0% | n/a | €255.3m | €13.25 | PE50.6x | E56.3% | n/a | Capital Goods | ||
ALKT | US$23.87 | -19.3% | 2.5% | US$2.8b | US$43.30 | PS7.3x | E85.2% | n/a | Software | ||
AGP | €6.81 | -5.7% | -17.0% | €124.2m | €12.00 | PE18.3x | E29.0% | n/a | Capital Goods | ||
MBTN | CHF 1.30 | -21.4% | -97.1% | CHF 40.0m | CHF 6.03 | PS0.5x | E109.3% | n/a | Semiconductors | ||
TGTX | US$39.23 | 14.0% | 139.6% | US$5.6b | US$42.83 | PE243.6x | E37.8% | n/a | Pharmaceuticals & Biotech | ||
TEND3 | R$14.57 | -1.1% | 28.8% | R$1.8b | R$18.95 | PE27.3x | E74.3% | 1.2% | Consumer Durables | ||
LAVV3 | R$9.05 | 5.2% | -0.9% | R$1.8b | R$12.47 | PE5.7x | E22.8% | 3.1% | Real Estate Management and Development |